ABVX Chart
See on advanced chart >
About
Abivax Sa is incorporated under the laws of France on December 4, 2013. The company is a clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients...
Read More
- HighlightA biotechnology company focused on harnessing the body's natural regulatory mechanisms to modulate the clinical stages of chronic inflammatory diseases
- ExchangeNASDAQ
- Listing Date10/20/2023
- Established Date12/04/2013
- Full-time Employees61
- Address7-11 boulevard Haussmann 75009 Paris France
- Tel33-1-53830963
- Website
- Fiscal Year End Date12/31
- Security TypeAmerican Depositary Receipt (Common Stock)
Industry
Biotechnology